USD 1.21
(1.68%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 5.59 Million USD | -16.08% |
2023 | 6.66 Million USD | 14.83% |
2022 | 5.8 Million USD | -15.27% |
2021 | 6.85 Million USD | -10.89% |
2020 | 7.69 Million USD | 21.97% |
2019 | 6.3 Million USD | 13.41% |
2018 | 5.55 Million USD | -15.5% |
2017 | 6.57 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 5.67 Million USD | -24.0% |
2024 Q3 | 6.04 Million USD | 6.49% |
2024 FY | 5.59 Million USD | -16.08% |
2024 Q4 | 5.59 Million USD | -7.37% |
2024 Q1 | 7.46 Million USD | 11.94% |
2023 FY | 6.66 Million USD | 14.83% |
2023 Q1 | 4.96 Million USD | -14.52% |
2023 Q4 | 6.66 Million USD | 40.61% |
2023 Q3 | 4.74 Million USD | -39.09% |
2023 Q2 | 7.78 Million USD | 56.84% |
2022 Q4 | 5.8 Million USD | 2.67% |
2022 FY | 5.8 Million USD | -15.27% |
2022 Q3 | 5.65 Million USD | 8.95% |
2022 Q1 | 5.6 Million USD | -18.19% |
2022 Q2 | 5.19 Million USD | -7.4% |
2021 Q4 | 6.85 Million USD | 334.47% |
2021 Q2 | 1.18 Million USD | -80.11% |
2021 FY | 6.85 Million USD | -10.89% |
2021 Q1 | 5.95 Million USD | -22.58% |
2021 Q3 | 1.57 Million USD | 33.17% |
2020 Q1 | 6.95 Million USD | 10.24% |
2020 Q3 | 7.82 Million USD | 0.0% |
2020 FY | 7.69 Million USD | 21.97% |
2020 Q4 | 7.69 Million USD | -1.66% |
2019 Q3 | 6.01 Million USD | 0.0% |
2019 FY | 6.3 Million USD | 13.41% |
2019 Q4 | 6.3 Million USD | 4.79% |
2018 Q4 | 5.55 Million USD | 0.0% |
2018 FY | 5.55 Million USD | -15.5% |
2017 FY | 6.57 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 40.22 Million USD | 86.089% |
Applied DNA Sciences, Inc. | 8.77 Million USD | 36.262% |
Aspira Women's Health Inc. | 8.62 Million USD | 35.138% |
Biodesix, Inc. | 94.51 Million USD | 94.08% |
BioNexus Gene Lab Corp. | 1.74 Million USD | -221.232% |
bioAffinity Technologies, Inc. | 3.36 Million USD | -66.226% |
bioAffinity Technologies, Inc. | 3.36 Million USD | -66.226% |
Bionano Genomics, Inc. | 118.24 Million USD | 95.268% |
CareDx, Inc | 223.28 Million USD | 97.494% |
Check-Cap Ltd. | 1.33 Million USD | -320.727% |
Castle Biosciences, Inc. | 86.54 Million USD | 93.534% |
DarioHealth Corp. | 38.24 Million USD | 85.369% |
Exact Sciences Corporation | 3.32 Billion USD | 99.832% |
Fulgent Genetics, Inc. | 139.82 Million USD | 95.998% |
Guardant Health, Inc. | 1.62 Billion USD | 99.656% |
ICON Public Limited Company | 7.74 Billion USD | 99.928% |
IDEXX Laboratories, Inc. | 1.77 Billion USD | 99.685% |
Illumina, Inc. | 4.36 Billion USD | 99.872% |
iSpecimen Inc. | 6.07 Million USD | 7.937% |
Standard BioTools Inc. | 159.86 Million USD | 96.5% |
MDxHealth SA | 121.92 Million USD | 95.411% |
23andMe Holding Co. | 206.64 Million USD | 97.292% |
Medpace Holdings, Inc. | 1.09 Billion USD | 99.49% |
Myriad Genetics, Inc. | 312.9 Million USD | 98.212% |
Mainz Biomed B.V. | 12.15 Million USD | 53.982% |
ENDRA Life Sciences Inc. | 1.09 Million USD | -410.947% |
NeoGenomics, Inc. | 739.69 Million USD | 99.244% |
Neogen Corporation | 1.44 Billion USD | 99.611% |
Inotiv, Inc. | 588.04 Million USD | 99.048% |
Natera, Inc. | 691.79 Million USD | 99.191% |
OpGen, Inc. | 13.44 Million USD | 58.377% |
OPKO Health, Inc. | 622.47 Million USD | 99.101% |
Psychemedics Corporation | 6.59 Million USD | 15.191% |
Prenetics Global Limited | 44.01 Million USD | 87.286% |
Prenetics Global Limited | 44.01 Million USD | 87.286% |
Precipio, Inc. | 3.67 Million USD | -52.388% |
Personalis, Inc. | 95.65 Million USD | 94.15% |
RadNet, Inc. | 2.07 Billion USD | 99.73% |
Sera Prognostics, Inc. | 25.28 Million USD | 77.868% |
Sotera Health Company | 2.68 Billion USD | 99.792% |
Neuronetics, Inc. | 81.64 Million USD | 93.146% |
Star Equity Holdings, Inc. | 21.67 Million USD | 74.184% |
Star Equity Holdings, Inc. | 21.67 Million USD | 74.184% |
Trinity Biotech plc | 83.38 Million USD | 93.289% |
T2 Biosystems, Inc. | 62.83 Million USD | 91.094% |
Twist Bioscience Corporation | 152.97 Million USD | 96.342% |
Exagen Inc. | 34.25 Million USD | 83.662% |